Akso Health
Akso Health
AHG
NASDAQ
0.97
USD
-18.49%
About
Akso Health Group, formerly Xiaobai Maimai Inc, is a China-based company mainly engaged in e-commerce business. The Company provides services through the Xiaobai Maimai application (APP), a one-stop e-commerce platform. The Company provides products covering food and beverage, wine, cosmetic products, fashion and apparel, entertainment, houseware, home appliances and others.
The Company is also engaged in social e-commerce platform business, cancer therapy and radiotherapy oncology service provider business, and the sale of coronavirus disease 2019 (COVID-19) Rapid Antigen Tests..
Financials Amount (in millions)
Income statement
Balance sheet
Cash flow
Ratios
| Price and Volume | |
|---|---|
| Volume | |
| Ten Day Average Volume | 6.8K |
| Three Month Average Volume | 701.2K |
| High Low | |
| Fifty-Two Week High | 2.9 USD |
| Fifty-Two Week Low | 0.53 USD |
| Fifty-Two Week High Date | 02 Feb 2024 |
| Fifty-Two Week Low Date | 13 Dec 2023 |
| Price and Volume | |
| Current Price | 0.97 USD |
| Beta | 0 |
| Relative Price Change | |
| Four Week Relative Price Change | 0.43% |
| Thirteen Week Relative Price Change | -17.61% |
| Twenty-Six Week Relative Price Change | -36.53% |
| Fifty-Two Week Relative Price Change | -15.86% |
| Year-to-Date Relative Price Change | 10.69% |
| Price Change | |
| One Day Price Change | -3.96% |
| Thirteen Week Price Change | -11.82% |
| Twenty-Six Week Price Change | -30.22% |
| Five Day Price Change | -7.62% |
| Fifty-Two Week Price Change | 5.43% |
| Year-to-Date Price Change | 31.08% |
| Month-to-Date Price Change | 7.66% |
| Per Share Data | |
|---|---|
| Book Value | |
| Book Value Per Share (Last Fiscal Year) | -99999.99 USD |
| Book Value Per Share (Most Recent Quarter) | -99999.99 USD |
| Tangible Book Value Per Share (Last Fiscal Year) | -99999.99 USD |
| Tangible Book Value Per Share (Most Recent Quarter) | -99999.99 USD |
| EBITD | |
| EBITD Per Share (Trailing Twelve Months) | -0.18312 USD |
| Revenue | |
| Revenue Per Share (Last Fiscal Year) | 0.05118 USD |
| Revenue Per Share (Trailing Twelve Months) | 0.05118 USD |
| Dividend | |
| Dividend Per Share (Last Fiscal Year) | -99999.99 USD |
| Dividend Per Share (Trailing Twelve Months) | 0 USD |
| Dividend Per Share (5 Year) | -99999.99 USD |
| Earnings Per Share | |
| Excluding Extraordinary Items (Last Fiscal Year) | -0.19203 USD |
| Excluding Extraordinary Items (Trailing Twelve Months) | -0.21789 USD |
| Normalized (Last Fiscal Year) | -0.19203 USD |
| Basic Excluding Extraordinary Items (Last Fiscal Year) | -0.19203 USD |
| Basic Excluding Extraordinary Items (Trailing Twelve Months) | -0.21789 USD |
| Including Extraordinary Items (Last Fiscal Year) | -0.20052 USD |
| Including Extraordinary Items (Trailing Twelve Months) | -0.23517 USD |
| Cash | |
| Cash Per Share (Last Fiscal Year) | -99999.99 USD |
| Cash Per Share (Most Recent Quarter) | -99999.99 USD |
| Cash Flow Per Share (Last Fiscal Year) | -0.19327 USD |
| Cash Flow Per Share (Trailing Twelve Months) | -0.19327 USD |
| Free Cash Flow Per Share (Trailing Twelve Months) | 0.02864 USD |
| Margins | |
|---|---|
| Cash Flow Revenue | |
| Cash Flow Revenue (5 Year) | -207 |
| Cash Flow Revenue (Trailing Twelve Months) | 56 |
| Pretax Margin | |
| Pretax Margin (Trailing Twelve Months) | -376.57% |
| Pretax Margin (Last Fiscal Year) | -376.57% |
| Pretax Margin (5 Year) | -271.25% |
| Gross Margin | |
| Gross Margin (Last Fiscal Year) | 5.06% |
| Gross Margin (Trailing Twelve Months) | 5.06% |
| Gross Margin (5 Year) | -99,999.99% |
| Operating Margin | |
| Operating Margin (Last Fiscal Year) | -357.78% |
| Operating Margin (Trailing Twelve Months) | -357.78% |
| Operating Margin (5 Year) | -275.38% |
| Net Profit Margin | |
| Net Profit Margin (Last Fiscal Year) | -377.61% |
| Net Profit Margin (Trailing Twelve Months) | -377.61% |
| Net Profit Margin (5 Year) | -273.44% |
| Growth | |
|---|---|
| Book Value | |
| Book Value Per Share (5 Year) | -99,999.99% |
| Tangible Book Value (5 Year) | 1.81% |
| Free Operating Cash Flow | |
| Free Operating Cash Flow (5 Year) | -99,999.99% |
| Revenue | |
| Revenue Change MRQ vs 1 Year Ago | 16.16% |
| Revenue Growth (3 Year) | -8.16% |
| Revenue Change (Trailing Twelve Months) | -81.66% |
| Revenue Per Share Growth | -25.81% |
| Revenue Growth (5 Year) | -99,999.99% |
| Capital Spending Debt | |
| Capital Spending (5 Year) | -99,999.99% |
| Total Debt (5 Year) | -36.90% |
| Dividends | |
| Dividend Growth (3 Year) | -99,999.99% |
| Earnings Per Share | |
| EPS Change MRQ vs 1 Year Ago | 86.31% |
| EPS Change (Trailing Twelve Months) | 59.74% |
| EPS Growth (3 Year) | -99,999.99% |
| EPS Growth (5 Year) | -99,999.99% |
| EBITDA | |
| EBITDA (5 Year) | -99,999.99% |
| EBITDA (5 Year Interim) | -99,999.99% |
| Net Profit Margin | |
| Net Profit Margin Growth (5 Year) | -99,999.99% |
| Valuation | |
|---|---|
| Total Price to Book | |
| Price to Tangible Book (Last Fiscal Year) | 2 |
| Price to Tangible Book (Most Recent Quarter) | 2 |
| Price to Free Cash Flow | |
| Price to Free Cash Per Share (Last Fiscal Year) | 171 |
| Price to Free Cash Per Share (Trailing Twelve Months) | 171 |
| Net Debt | |
| Net Debt (Most Recent Quarter) | -83,174,020 |
| Net Debt (Last Fiscal Year) | -83,174,020 |
| Price to Sales | |
| Price to Sales (Last Fiscal Year) | 96 |
| Price to Sales (Trailing Twelve Months) | 96 |
| Price to Earnings | |
| PE Excluding Extraordinary Items (Last Fiscal Year) | -100,000 |
| PE Normalized (Last Fiscal Year) | -100,000 |
| PE Basic Excluding Extraordinary Items (Trailing Twelve Months) | -100,000 |
| PE Excluding Extraordinary Items High (Trailing Twelve Months) | 8 |
| PE Excluding Extraordinary Items Low (Trailing Twelve Months) | 3 |
| PE Including Extraordinary Items (Trailing Twelve Months) | -100,000 |
| Dividends | |
| Dividend Yield (5 Year) | -99,999.99% |
| Dividend Yield | -99,999.99% |
| Current Dividend Yield | 0.00% |
| Price to Book | |
| Price to Book (Last Fiscal Year) | -100,000 |
| Price to Book (Most Recent Quarter) | -100,000 |
| Financial Strength | |
|---|---|
| Debt to Equity | |
| Long Term Debt to Equity (Last Fiscal Year) | 0 |
| Long Term Debt to Equity (Most Recent Quarter) | 0 |
| Payout Ratio | |
| Payout Ratio (Last Fiscal Year) | -99,999.99% |
| Payout Ratio (Trailing Twelve Months) | -99,999.99% |
| Quick Ratio | |
| Quick Ratio (Last Fiscal Year) | 39 |
| Quick Ratio (Most Recent Quarter) | 39 |
| Enterprise Value | |
| Current Enterprise Value to Free Cash Flow (Last Fiscal Year) | -100,000 |
| Current Enterprise Value to Free Cash Flow (Trailing Twelve Months) | -100,000 |
| Current Ratio | |
| Current Ratio (Last Fiscal Year) | 40 |
| Current Ratio (Most Recent Quarter) | 40 |
| Free Cash Flow | |
| Free Cash Flow (Last Fiscal Year) | 1.4M |
| Free Cash Flow (Trailing Twelve Months) | 1.4M |
| Net Interest Coverage | |
| Net Interest Coverage (Last Fiscal Year) | -15 |
| Net Interest Coverage (Trailing Twelve Months) | -15 |
| Total Debt to Equity | |
| Total Debt to Equity (Last Fiscal Year) | 1 |
| Total Debt to Equity (Most Recent Quarter) | 1 |
| Management Effectiveness | |
|---|---|
| Return on Assets | |
| Return on Assets (Last Fiscal Year) | -11.22% |
| Return on Assets (Trailing Twelve Months) | -11.22% |
| Return on Assets (5 Year) | -22.08% |
| Return on Equity | |
| Return on Equity (Last Fiscal Year) | -12.32% |
| Return on Equity (Trailing Twelve Months) | -12.32% |
| Return on Equity (5 Year) | -35.65% |
| Return on Investment | |
| Return on Investment (Last Fiscal Year) | -12.40% |
| Return on Investment (Trailing Twelve Months) | -12.40% |
| Return on Investment (5 Year) | -31.32% |